This activity is supported by an educational grant from Blueprint Medicines.

Hi, I'm Prithvi Bose, professor in the Department of Leukemia at MD Anderson Cancer Center in Houston, Texas.

Today, we'll be talking about advanced systemic mastocytosis.

In this session, I will review diagnosing and recognizing advanced systemic mastocytosis.

Advanced SM is about 10% of all SM.

When it is just SM and there's no other hematologic neoplasm and you have organ damage, we see findings that's aggressive SM.

When you have SM with another associated hematologic neoplasm, that's SMAHN.

Let's summarize the

This activity is supported by an educational grant from Blueprint Medicines.

Hi, I'm Prithvi Bose, professor in the Department of Leukemia at MD Anderson Cancer Center in Houston, Texas.

Today, we'll be talking about advanced systemic mastocytosis.

In this session, I will review diagnosing and recognizing advanced systemic mastocytosis.

Advanced SM is about 10% of all SM.

When it is just SM and there's no other hematologic neoplasm and you have organ damage, we see findings that's aggressive SM.

When you have SM with another associated hematologic neoplasm, that's SMAHN.

Let's summarize the

This activity is supported by an educational grant from Blueprint Medicines.

Hi, I'm Prithvi Bose, professor in the Department of Leukemia at MD Anderson Cancer Center in Houston, Texas.

Today, we'll be talking about advanced systemic mastocytosis.

In this session, I will review diagnosing and recognizing advanced systemic mastocytosis.

Advanced SM is about 10% of all SM.

When it is just SM and there's no other hematologic neoplasm and you have organ damage, we see findings that's aggressive SM.

When you have SM with another associated hematologic neoplasm, that's SMAHN.

Let's summarize the

This activity is supported by an educational grant from Blueprint Medicines.

Hi, I'm Prithvi Bose, professor in the Department of Leukemia at MD Anderson Cancer Center in Houston, Texas.

Today, we'll be talking about advanced systemic mastocytosis.

In this session, I will review diagnosing and recognizing advanced systemic mastocytosis.

Advanced SM is about 10% of all SM.

When it is just SM and there's no other hematologic neoplasm and you have organ damage, we see findings that's aggressive SM.

When you have SM with another associated hematologic neoplasm, that's SMAHN.

Let's summarize the